All
Evidence-based guidance for psoriasis treatment
July 9th 2015Newer therapies to treat psoriasis and psoriatic arthritis are more likely to be successful in patients with no prior exposure to biologics. Traditional therapies remain an option but, unlike newer treatments, require monitoring for toxicities.
QUIZ: Tender nodules covering scalp. What’s Your Diagnosis?
July 7th 2015A 48 year old man presents with a 2 year history of painful, disseminated, tender nodules covering his scalp. Many lesions are inflammatory with purulent discharge, and alopecia is noted over nodules. The patient reports clinical worsening after mental and physical stress. He has been treated with oral antibiotics, such as clindamycin hydrochloride and erythromycin, with poor response.
Rapid responders may offer clues to optimize immune therapy
July 6th 2015Some patients respond more rapidly to immune therapies like ipilimumab, and clinicians have observed delayed toxicities with prolonged use of checkpoint inhibitors; effective treatments for subtypes of melanoma, such as uveal melanoma, have not yet emerged.
Rheumatology for the dermatologist
June 25th 2015The signs and symptoms of some dermatologic and rheumatologic diseases sometimes overlap, and a better understanding of their associations and subsequent clinical and laboratory evaluations can help in optimizing the treatment and management of this patient population.
Rejuvenation and Scars: tips you need to know for laser technologies
June 5th 2015Tina Alster, M.D., founding director of the Washington Institute of Dermatologic Laser Surgery in Washington, D.C. and clinical professor of dermatology at Georgetown University, talked with Dermatology Times’ Pamela Kreigh about the most important developments in laser scar revision and rejuvenation. Learn more
Farewell to Fredric S. Brandt, M.D.
June 5th 2015Fredric S. Brandt, M.D., one of cosmetic dermatology’s most celebrated, accomplished and recognized physicians, died April 5, 2015. His colleagues, still reeling from the loss, remember the legacy and brilliance of the man who came to be known as “The Baron of Botox.”
Clinical pearls in pediatric dermatology
June 3rd 2015Pediatric dermatology is a rewarding area of special interest for dermatologists. Overlapping conditions, the need for extra-gentle skin care, patient compliance, and medication adherence all present unique challenges for pediatric dermatologists. In part one of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses differentiating diseases and treatment recommendations with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
Immunotherapy Combo Appears Safe, Shrinks Metastatic Melanoma Tumors
June 2nd 2015Researchers conducting a first-of-its-kind study combining the checkpoint inhibitor tremelimumab with an anti-CD40 monoclonal antibody drug report the dual treatments are safe and produce a clinical response in metastatic melanoma patients. Learn more
FDA OKs melanoma drug after denying it accelerated approval
June 2nd 2015Two days after it reported that the Food and Drug Administration had denied accelerated approval to Amgen experimental melanoma drug talimogene laherparepvec (T-Vec), Reuters reported that an FDA advisory panel voted to approve the drug for marketing. Get details